AstraZeneca Nexium Relying On Healing Rate, Symptom Maintenance

AstraZeneca's efforts to build a superiority claim for the proton pump inhibitor Nexium hinge on three elements of labeling.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet